Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration approved Novo...
By Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) – Novo Nordisk’s widely used diabetes drug...
By Danilo Masoni MILAN (Reuters) – Clean energy stocks might be in for a much-needed...
By Lisa Baertlein LOS ANGELES (Reuters) -Toymaker Basic Fun’s team that oversees ocean shipments of...
WASHINGTON (Reuters) – Denmark’s Maersk is preparing to resume shipping operations in the Red Sea...
By Scott DiSavino NEW YORK (Reuters) – The U.S. offshore wind industry is eying a...
By Phil Stewart and John Davison MANAMA/DUBAI (Reuters) – The United States on Tuesday launched...
By Divya Rajagopal TORONTO (Reuters) – A handful of Canadian, German and Australian critical mineral...